Stock listing
NASDAQ:CLNN Clene Inc. Stock
Home listing (NASDAQ) of Clene Inc.
Follow Clene Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CLNN
$3.83 USD -0.07 (-1.8%)
Close on Oct 30, 2026
- Day range
- $3.75 – $3.95 USDOct 30, 2026
- Volume
- 47,081 sharesOct 30, 2026
- Market cap
- $54.44M USDAt the close on Oct 30, 2026 · price × 14.21M shares outstanding
- 52-week range
- $3.02 – $13.50 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $417,413 USDMedian day 74,450 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CLNN · Home | $3.83 USD | -0.07 (-1.8%) | 47,081 | $3.75 | $3.95 | $3.75 | $3.90 | Close on Oct 30, 2026 |
| Frankfurt:84C0 | €3.42 EUR | +0.04 (+1.2%) | — | €3.38 | €3.42 | €3.38 | €3.38 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:CLNN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.83 | -0.07 | -1.8% | $3.75 | $3.95 | $3.75 | 47,081 | |
| $3.90 | -0.13 | -3.2% | $3.97 | $3.99 | $3.87 | 34,114 | |
| $4.03 | +0.06 | +1.5% | $3.96 | $4.05 | $3.90 | 43,856 | |
| $3.97 | +0.13 | +3.4% | $3.84 | $3.99 | $3.84 | 31,272 | |
| $3.84 | -0.04 | -1.0% | $3.92 | $3.92 | $3.78 | 33,858 | |
| $3.88 | 0.00 | 0.0% | $3.79 | $3.97 | $3.77 | 21,396 | |
| $3.88 | +0.12 | +3.2% | $3.73 | $4.01 | $3.63 | 124,247 | |
| $3.76 | +0.03 | +0.8% | $3.76 | $4.00 | $3.71 | 84,562 | |
| $3.73 | +0.44 | +13.4% | $3.52 | $4.05 | $3.196 | 202,009 | |
| $3.29 | +0.19 | +6.1% | $3.30 | $3.391 | $3.10 | 88,490 | |
| $3.10 | -0.21 | -6.3% | $3.39 | $3.39 | $3.02 | 204,400 | |
| $3.31 | 0.00 | 0.0% | $3.25 | $3.44 | $3.20 | 134,000 | |
| $3.31 | -0.08 | -2.4% | $3.38 | $3.40 | $3.24 | 71,400 | |
| $3.39 | -0.29 | -7.9% | $3.69 | $3.70 | $3.36 | 114,700 | |
| $3.68 | -0.18 | -4.7% | $3.93 | $3.93 | $3.67 | 73,700 | |
| $3.86 | -0.02 | -0.5% | $3.83 | $3.96 | $3.80 | 48,100 | |
| $3.88 | -0.04 | -1.0% | $3.94 | $3.96 | $3.77 | 82,300 | |
| $3.92 | +0.05 | +1.3% | $3.85 | $4.01 | $3.71 | 40,500 | |
| $3.87 | -0.04 | -1.0% | $3.92 | $4.04 | $3.80 | 45,000 | |
| $3.91 | -0.17 | -4.2% | $4.09 | $4.11 | $3.80 | 278,200 | |
| $4.08 | +0.06 | +1.5% | $4.08 | $4.17 | $3.97 | 61,500 | |
| $4.02 | -0.06 | -1.5% | $4.10 | $4.15 | $4.00 | 100,000 | |
| $4.08 | -0.02 | -0.5% | $4.14 | $4.33 | $4.01 | 51,800 | |
| $4.10 | +0.04 | +1.0% | $4.10 | $4.26 | $4.06 | 70,400 | |
| $4.06 | -0.24 | -5.6% | $4.24 | $4.37 | $4.01 | 91,700 | |
| $4.30 | +0.09 | +2.1% | $4.15 | $4.49 | $4.12 | 136,400 | |
| $4.21 | -0.08 | -1.9% | $4.27 | $4.38 | $4.09 | 47,700 | |
| $4.29 | -0.09 | -2.1% | $4.36 | $4.44 | $4.15 | 75,200 | |
| $4.38 | -0.16 | -3.5% | $4.51 | $4.70 | $4.27 | 135,800 | |
| $4.54 | +0.19 | +4.4% | $4.40 | $4.70 | $4.40 | 108,900 | |
| $4.35 | +0.20 | +4.8% | $4.16 | $4.44 | $4.05 | 191,400 | |
| $4.15 | +0.29 | +7.5% | $3.86 | $4.23 | $3.81 | 138,800 | |
| $3.86 | -0.16 | -4.0% | $4.05 | $4.37 | $3.84 | 255,800 | |
| $4.02 | +0.74 | +22.6% | $3.25 | $4.18 | $3.25 | 478,800 | |
| $3.28 | -0.29 | -8.1% | $3.57 | $3.72 | $3.26 | 140,900 | |
| $3.57 | -0.08 | -2.2% | $3.72 | $3.76 | $3.52 | 125,000 | |
| $3.65 | -0.07 | -1.9% | $3.67 | $3.93 | $3.61 | 113,000 | |
| $3.72 | +0.10 | +2.8% | $3.67 | $3.84 | $3.48 | 159,300 | |
| $3.62 | -0.23 | -6.0% | $3.82 | $3.82 | $3.60 | 252,600 | |
| $3.85 | -0.15 | -3.7% | $3.92 | $4.00 | $3.72 | 122,600 | |
| $4.00 | -0.16 | -3.8% | $4.18 | $4.22 | $3.75 | 145,000 | |
| $4.16 | +0.05 | +1.2% | $4.10 | $4.28 | $3.88 | 107,600 | |
| $4.11 | -0.17 | -4.0% | $4.22 | $4.42 | $4.02 | 159,100 | |
| $4.28 | +0.05 | +1.2% | $4.31 | $4.32 | $4.11 | 41,300 | |
| $4.23 | -0.24 | -5.4% | $4.43 | $4.74 | $4.17 | 59,700 | |
| $4.47 | -0.18 | -3.9% | $4.67 | $4.80 | $4.40 | 33,000 | |
| $4.65 | +0.21 | +4.7% | $4.43 | $4.75 | $4.26 | 89,900 | |
| $4.44 | +0.005 | +0.1% | $4.47 | $4.58 | $4.20 | 112,100 | |
| $4.435 | +0.115 | +2.7% | $4.31 | $4.53 | $4.24 | 37,313 | |
| $4.32 | -0.05 | -1.1% | $4.40 | $4.41 | $4.13 | 28,900 | |
| $4.37 | +0.18 | +4.3% | $4.24 | $4.37 | $4.10 | 23,100 | |
| $4.19 | +0.10 | +2.4% | $4.18 | $4.34 | $4.10 | 49,300 | |
| $4.09 | -0.11 | -2.6% | $4.19 | $4.47 | $4.08 | 73,400 | |
| $4.20 | +0.06 | +1.4% | $4.14 | $4.40 | $4.10 | 59,400 | |
| $4.14 | -0.05 | -1.2% | $4.16 | $4.25 | $4.10 | 59,000 | |
| $4.19 | +0.12 | +2.9% | $4.15 | $4.22 | $4.01 | 71,800 | |
| $4.07 | -0.30 | -6.9% | $4.38 | $4.46 | $3.96 | 166,100 | |
| $4.37 | -0.79 | -15.3% | $5.06 | $5.11 | $4.35 | 265,761 | |
| $5.16 | -0.12 | -2.3% | $5.30 | $5.35 | $4.14 | 300,961 | |
| $5.28 | -0.06 | -1.1% | $5.37 | $5.57 | $5.27 | 50,300 | |
| $5.34 | -0.04 | -0.7% | $5.40 | $5.56 | $5.31 | 22,200 | |
| $5.38 | +0.10 | +1.9% | $5.40 | $5.48 | $5.26 | 46,500 | |
| $5.28 | +0.09 | +1.7% | $5.33 | $5.42 | $5.23 | 46,000 | |
| $5.19 | +0.17 | +3.4% | $5.01 | $5.31 | $5.01 | 27,300 | |
| $5.02 | -0.02 | -0.4% | $5.04 | $5.43 | $4.94 | 33,700 | |
| $5.04 | +0.32 | +6.8% | $4.78 | $5.13 | $4.78 | 37,300 |
- Ticker
- NASDAQ:CLNN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 19, 2026
Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS
Latest deck · Aug 10, 2026
Investor Presentation (August 2026)
Investor deck · 25 slides
Latest news
Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS
Oct 19, 2026
Closed $3.29 (+6.1%) on Oct 19, 2026
Clene to Present at Upcoming Investor Conferences
Sep 22, 2026
Closed $4.38 (-3.5%) on Sep 22, 2026
Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA
Sep 21, 2026
Closed $4.54 (+4.4%) on Sep 21, 2026
Clene Announces $4 Million Registered Direct Offering
Sep 15, 2026
Closed $4.02 (+22.6%) on Sep 15, 2026
Clene to Present at Upcoming September Investor Conferences
Sep 3, 2026
Closed $4.00 (-3.8%) on Sep 3, 2026
Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights
Aug 14, 2026
Closed $4.14 (-1.2%) on Aug 14, 2026
Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval
Aug 10, 2026
Closed $5.16 (-2.3%) on Aug 10, 2026
Clene to Present at The Canaccord 46th Annual Growth Conference
Jul 29, 2026
Closed $4.72 (-5.4%) on Jul 29, 2026
Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights
May 14, 2026
Closed $7.05 (+8.5%) on May 14, 2026
Clene Announces $7 Million Underwritten Offering of Common Stock
May 5, 2026
Closed $6.58 (-18.7%) on May 5, 2026
Financings
Registered direct offering of common stock
Sep 21, 2026
Closed: US$4M raised · US$3.28 a share
Buyers: David Matlin (Led the offering); Kensington Capital Holdings
Insiders: Led by the Chairman of the Board, David Matlin, alongside the Chief Executive Officer and other existing shareholders including insiders
Use of proceeds: Fund operations through mid-first quarter 2027, beyond the potential FDA decision on accepting the CNM-Au8 NDA for review
Decks
Investor Presentation (August 2026)
Investor deck · 25 slides · Aug 10, 2026
Corporate Update (October 2025)
Corporate update · 32 slides · Oct 14, 2025
Investor Presentation (November 2024)
Investor deck · 30 slides · Nov 13, 2024
Investor Presentation (August 2024)
Investor deck · 38 slides · Aug 6, 2024
Clene Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 20 in the last 12 months · 125 in all · newest Oct 19, 2026 · oldest 2021
- Decks
- 44 decks · latest Aug 10, 2026
Where Clene Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CLNN · Home listing · This page | NASDAQ | United States | USD |
| BOATS:CLNN | BOATS | United States | USD |
| Frankfurt:84C0 | Frankfurt | Germany | EUR |
| Tradegate:84C0 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Clene Inc.